Oxidized LDL-Mediated Macrophage Survival Involves Elongation Factor-2 Kinase

被引:41
|
作者
Chen, Johnny H. [1 ]
Riazy, Maziar [1 ]
Smith, Ewan M. [2 ]
Proud, Christopher G. [3 ]
Steinbrecher, Urs P. [1 ]
Duronio, Vincent [1 ]
机构
[1] Univ British Columbia, Dept Med, Vancouver, BC V6H 3Z6, Canada
[2] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England
[3] Univ Southampton, Sch Biol Sci, Southampton SO9 5NH, Hants, England
关键词
oxidized LDL; eEF2; kinase; macrophage; apoptosis; calcium; LOW-DENSITY-LIPOPROTEIN; COLONY-STIMULATING FACTOR; MR 100,000 SUBSTRATE; FACTOR-II; FOAM CELLS; PHOSPHATIDYLINOSITOL; 3-KINASE; SIGNALING PATHWAYS; MAMMALIAN-CELLS; PHOSPHORYLATION; GROWTH;
D O I
10.1161/ATVBAHA.108.174599
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Macrophage survival and proliferation is believed to be a contributing factor in the development of early atherosclerotic lesions. Oxidized low density lipoprotein (oxLDL), a key mediator in the pathogenesis of this disease, has been shown to block apoptosis in macrophages deprived of growth factor. In this report, we investigate the mechanism of oxLDL-mediated macrophage survival. Methods and Results-OxLDL, but not native LDL (nLDL), induces an immediate and oscillatory increase in intracellular calcium ([Ca2+](i)). We also show that the calcium/calmodulin dependent kinase, eukaryotic elongation factor-2 kinase (eEF2 kinase), is activated in response to oxLDL, an effect that can be blocked by inhibiting calcium mobilization. Furthermore, selective inhibition of eEF2 kinase reverses the prosurvival effect of oxLDL and results in cellular apoptosis. p38 MAP kinase, a negative regulator of eEF2 kinase, is activated on growth factor withdrawal, a response that can be inhibited by oxLDL. Finally, we show that oxLDL, by activating eEF2 kinase, phosphorylates and therefore inhibits eEF2, resulting in an overall decrease in protein synthesis. Conclusion-These results indicate a novel signaling pathway in which oxLDL can block macrophage apoptosis by mobilizing calcium and activating eEF2 kinase. (Arterioscler Thromb Vasc Biol. 2009; 29: 92-98.)
引用
收藏
页码:92 / U238
页数:20
相关论文
共 50 条
  • [31] Elongation factor-2 kinase: Immunological evidence for the existence of tissue-specific isoforms
    Hait, WN
    Ward, MD
    Trakht, IN
    Ryazanov, AG
    FEBS LETTERS, 1996, 397 (01) : 55 - 60
  • [32] Inhibition of Elongation Factor-2 Kinase Augments the Antitumor Activity of Temozolomide against Glioma
    Liu, Xiao-yuan
    Zhang, Li
    Wu, JianPing
    Zhou, Lei
    Ren, Yi-Jie
    Yang, Wei-Qiong
    Ming, Zi-Jun
    Chen, Bo
    Wang, Jianrong
    Zhang, Yi
    Yang, Jin-Ming
    PLOS ONE, 2013, 8 (11):
  • [33] Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase
    Ryazanov, A. G.
    Ward, M. D.
    Mendola, C. E.
    Pavur, K. S.
    Proceedings of the National Academy of Sciences of the United States of America, 94 (10):
  • [34] Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase
    Ryazanov, AG
    Ward, MD
    Mendola, CE
    Pavur, KS
    Dorovkov, MV
    Wiedmann, M
    ErdjumentBromage, H
    Tempst, P
    Parmer, TG
    Prostko, CR
    Germino, FJ
    Hait, WN
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) : 4884 - 4889
  • [35] P-gingivalis lipopolysaccharide-induced exacerbation of oxidized LDL-mediated macrophage foam cell formation is reliant on TRPV4 channels
    Rahaman, Shaik O.
    Gupta, Nabyendu
    Goswami, Rishov
    FASEB JOURNAL, 2018, 32 (01):
  • [36] MMP-9 Inhibition by ACE Inhibitor Reduces Oxidized LDL-Mediated Foam-Cell Formation
    Kojima, Chiari
    Ino, Jun
    Ishii, Hideto
    Nitta, Kosaku
    Yoshida, Masayuki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (01) : 97 - 105
  • [37] VITAMIN-E, LDL, AND ENDOTHELIUM - BRIEF ORAL VITAMIN SUPPLEMENTATION PREVENTS OXIDIZED LDL-MEDIATED VASCULAR INJURY IN-VITRO
    BELCHER, JD
    BALLA, J
    BALLA, G
    JACOBS, DR
    GROSS, M
    JACOB, HS
    VERCELLOTTI, GM
    ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (12): : 1779 - 1789
  • [38] Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer
    Fu, L. L.
    Xie, T.
    Zhang, S. Y.
    Liu, B.
    APOPTOSIS, 2014, 19 (10) : 1527 - 1531
  • [39] Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer
    L. L. Fu
    T. Xie
    S. Y. Zhang
    B. Liu
    Apoptosis, 2014, 19 : 1527 - 1531
  • [40] Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancer
    Erdogan, Mumin Alper
    Ashour, Ahmed
    Yuca, Erkan
    Gorgulu, Kivanc
    Ozpolat, Bulent
    CELLULAR SIGNALLING, 2021, 81